Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Metastatic Pancreatic Adenocarcinoma
Clinical Trial
NCT01360853Last updated: 12/4/2025
TRAW
Traws Pharma, Inc.
